Results 121 to 130 of about 19,828 (226)

Organ-Specific Distribution of Antimycobacterial Neolignans in Piper rivinoides and UHPLC-HRMS/MS Analysis of Its Extracts

open access: yesMolecules
This multidisciplinary study investigates Piper rivinoides, a Brazilian medicinal species, focusing on its chemical composition and antimycobacterial potential.
Jéssica Sales Felisberto   +13 more
doaj   +1 more source

Antimycobacterial activity of lichen metabolites in vitro

open access: yesEuropean Journal of Pharmaceutical Sciences, 1998
Several compounds, whose structures represent the most common chemical classes of lichen metabolites, were screened for in vitro activity against Mycobacterium aurum, a non-pathogenic organism with a similar sensitivity profile to M. tuberculosis. Of the compounds tested, usnic acid from Cladonia arbuscula exhibited the highest activity with an MIC ...
K, Ingólfsdóttir   +4 more
openaire   +2 more sources

ANTIMYCOBACTERIAL AND CYTOTOXIC PERFORMANCE OF THE TRIAZOLE COMPOUND 177 IN FREE AND NANOENCAPSULATED FORMS AGAINST MYCOBACTERIUM TUBERCULOSIS

open access: yesBrazilian Journal of Infectious Diseases
Introduction/Objectives: The development of new bioactive compounds is a promising strategy against tuberculosis (TB), a disease caused mainly by Mycobacterium tuberculosis (Mtb).
Fábio Rocha Formiga   +12 more
doaj   +1 more source

Era of direct acting anti-viral agents for the treatment of hepatitis C. [PDF]

open access: yes, 2018
Hepatitis C infection is universal and the most common indication of liver transplantation in the United States. The period of less effective interferon therapy with intolerable side effects has gone.
Ahmed, Monjur
core   +1 more source

Exploring Antimycobacterial Potential: Safety Evaluation and Active Compound Isolation from Gymnopilus junonius

open access: yesAntibiotics
Background/Objectives: Tuberculosis remains a major public health crisis, and it is imperative to search for new antimycobacterial drugs. Natural products, including medicinal macrofungi, have been used as sources for the discovery of pharmaceuticals ...
Jenske Didloff   +8 more
doaj   +1 more source

Перспективи застосування гетероциклічних сполук для лікування хворих на туберкульоз легень [PDF]

open access: yes, 2014
Основна причина погіршення епідемічної ситуації з туберкульозу (ТБ) полягає в зміні біологічних властивостей мікобактерій (МБТ) під впливом антимікобактеріальних препаратів (АМБП) із розвитком полі- та мультирезистентних штамів М ...
Єременчук, Інга Василівна
core  

Antimycobacterial Activity of Hedeoma drummondii against Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria. [PDF]

open access: yesAntibiotics (Basel), 2023
Molina-Torres C   +5 more
europepmc   +1 more source

Phytochemical characterization and antitubercular potential of three Moroccan essential oils: A combined experimental and in silico investigation

open access: yesScientific African
Introduction/Objective: Tuberculosis (TB) remains a major health concern, especially with the rise of multidrug-resistant Mycobacterium tuberculosis strains.
Nesrine Benkhaira   +6 more
doaj   +1 more source

Antimycobacterial Activity of Sida hermaphrodita (L.) Rusby (Malvaceae) Seed Extract. [PDF]

open access: yesCells, 2023
Lewtak K   +6 more
europepmc   +1 more source

Interaction of mycobacterium tuberculosis with the host cells: a focus in the molecular mechanism involved in trafficking and autophagy [PDF]

open access: yes, 2018
Tuberculosis (TB) is an ancient disease remaining a serious health threat worldwide. It is caused by Mycobacterium tuberculosis (Mtb), an acid-fast bacilli, non-sporulated, slow-growing, immobile and aerobic.
Colombo, Maria Isabel   +2 more
core  

Home - About - Disclaimer - Privacy